Related Experiment Videos
[Cardiovascular effect mediated by phencyclidine receptor in central nervous system]
Sheng Li Xue Bao : [Acta Physiologica Sinica]
|February 1, 1990
Summary
Central phencyclidine (PCP) receptors inhibit cardiovascular function, causing hypotension and bradycardia when activated within the brain. Peripheral PCP receptor effects differ, suggesting complex cardiovascular regulation.
Area of Science:
- Neuropharmacology
- Cardiovascular Physiology
Context:
- Phencyclidine (PCP) receptor's cardiovascular effects are increasingly studied, yet central mechanisms remain unclear.
- Investigating the role of central PCP receptors in regulating blood pressure and heart rate is crucial.
Purpose:
- To elucidate the cardiovascular function of central phencyclidine (PCP) receptors.
- To differentiate the effects of central versus systemic PCP administration on cardiovascular parameters.
Summary:
- Central administration of PCP or its agonist TCP into the brain or spinal cord induced hypotension and bradycardia.
- Systemic PCP administration resulted in hypertension, indicating distinct central and peripheral actions.
- Dextrorphan antagonism of central PCP effects confirmed receptor involvement.
Impact:
- Findings reveal that central PCP receptors exert an inhibitory influence on the cardiovascular system.
- This research clarifies the complex cardiovascular actions of PCP, differentiating central and peripheral receptor contributions.